Topics

Clinical Trials About "986165 diflunisal Healthy Participants" RSS

00:17 EST 21st January 2020 | BioPortfolio

We list hundreds of Clinical Trials about "986165 diflunisal Healthy Participants" on BioPortfolio. We draw our references from global clinical trials data listed on ClinicalTrials.gov and refresh our database daily.

More Information about "986165 diflunisal Healthy Participants" on BioPortfolio

We have published hundreds of 986165 diflunisal Healthy Participants news stories on BioPortfolio along with dozens of 986165 diflunisal Healthy Participants Clinical Trials and PubMed Articles about 986165 diflunisal Healthy Participants for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of 986165 diflunisal Healthy Participants Companies in our database. You can also find out about relevant 986165 diflunisal Healthy Participants Drugs and Medications on this site too.

Showing "986165 diflunisal Healthy Participants" Clinical Trials 1–25 of 27,000+

Extremely Relevant

The Effects Diflunisal on the Levels of BMS-986165 in Healthy Participants

BMS-986165 Is broken down by the body through multiple pathways. This study Investigates the effect of blocking one pathway in the drug levels of BMS-986165 in health subjects.


A Taste Assessment of BMS-986165 in Healthy Participants

The purpose of this study is to assess the taste characteristics of BMS-986165 formulations, alone and mixed, in order to develop a pediatric oral form of BMS-986165.

An Investigational Study to Evaluate Experimental Medication BMS-986165 Given as a Tablet and Solution in Healthy Male Participants

The purpose of this study is to investigate BMS-986165 given as a tablet in healthy male participants.


Pharmacokinetics and Metabolism of [14C]BMS-986165 in Healthy Male Participants

An oral dose in healthy subjects to obtain information about the absorption, metabolism, and excretion (AME) of BMS-986165

An Investigational Study of Experimental Medication BMS-986165 in Healthy Participants

The purpose of this study is to investigate the effects of experimental medication BMS-986165 in healthy male participants.

Effect of BMS-986165 on the Pharmacokinetics of Rosuvastatin

The study is to assess the effect of coadministration of multiple doses of BMS-986165 on the systemic exposure of rosuvastatin in healthy participants.

An Investigational Study of Experimental Medication BMS-986165 in Healthy Participants to Study Electrocardiogram Effects

This is a study to investigate the experimental medication BMS-986165 in healthy participants in order to study the effects it has on electrocardiogram results.

An Investigational Study to Evaluate Experimental Medication BMS-986165 in Participants With Normal Kidney Function and Participants With Mild, Moderate, and Severe Kidney Damage and in Participants With End-Stage Kidney Disease on Dialysis

The purpose of this study is to investigate BMS-986165 in participants with different levels of kidney function.

Single and Multiple Dose Pharmacokinetics of BMS-986165 in a Randomized, Double-Blind, Placebo-Controlled Study in Healthy Chinese Subjects

Main objective of this study is to assess BMS-986165 plasma PK following single and multiple oral doses of BMS-986165 in healthy Chinese subjects.

A Study to Investigate the Effects of Gastric Acid Suppression by Rabeprazole and BMS-986165 on How Fast and Complete The Drug is Absorbed Into the Body of Healthy Participants

The purpose of this study is to evaluate the effects of stomach acid suppression by rabeprazole and BMS-986165 on how fast and complete the drug is absorbed into the body of healthy participants.

A Study Comparing the Effects of Famotidine Pretreatment and of Food on the Relative Bioavailability of BMS-986165 in Healthy Volunteers

The primary purpose of this study is to evaluate the effects of food and pH on the relative bioavailability (BA) of the tablet formulation of BMS-986165 in healthy volunteers

An Investigational Study of BMS-986165 in Participants With Normal Liver Function and Participants With Mild, Moderate and Severe Liver Damage

The purpose of this study is to investigate BMS-986165 in participants with different levels of liver function.

Study to Characterize the Effects of Cytochrome p450 1A2 Inhibition on Systemic Exposure to BMS-986165

To compare the pharmacokinetic characteristics of BMS-986165 after a single-dose administration alone vs. in combination with fluvoxamine (CYP1A2 inhibitor)

Efficacy and Safety of BMS-986165 Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA)

The main purpose of study is to assess the dose-response relationship of BMS-986165 (Dose A or Dose B once daily [QD]) at Week 16 in the treatment of participants with active PsA.

Assessment of Gut Absorption of Experimental Medication BMS-986165 in Healthy Males

The purpose of this study is to evaluate sites of gut absorption of BMS-986165 in males

A Study to Investigate BMS-986165 and Methotrexate in Healthy Male Patients

The purpose of this study is to investigate effects of BMS-986165 on blood levels of methotrexate given as a single dose in healthy male patients.

A Study to Investigate the Effects of Cytochrome P450 1A2 Induction by Ritonavir on BMS-986165 Drug Levels and Effects in Healthy Participants

The Study of Cytochrome P450 1A2 Induction by Ritonavir on the drug effects of BMS-986165 in Healthy Participants

An Investigational Study to Determine the Drug Level Profile of BMS-986165 in Healthy Male Volunteers Following Transporter Inhibition.

Study of what the body does to drug BMS-986165 when it is taken together with pyrimethamine

An Investigational Study of Cyclosporine on Experimental Medication BMS-986165 in Healthy Male Participants

This is an investigational study of Cyclosporine on the experimental medication BMS-986165 in healthy male participants.

The Effect of BMS-986165 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patients

The purpose of this study is to investigate the effect of BMS-986165 in combination with an oral contraceptive in healthy female patients.

An Investigational Study to Evaluate Experimental Medication BMS-986165 in Japanese Participants With Moderate-to-Severe Psoriasis

The purpose of this study is to investigate BMS-986165 given to Japanese participants with moderate-to-severe psoriasis.

Relevant

An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus Nephritis

The purpose of this study is to evaluate the safety and effectiveness of BMS-986165 compared with placebo with regard to measures of kidney function in participants with lupus nephritis (LN).

Long-Term Study That Measures the Safety and Efficacy of BMS-986165 in Participants With Psoriasis.

The main purpose of this study is to characterize the long-term safety and efficacy of the drug BMS-986165 in patients who have been previously enrolled in an applicable Phase 3 psoriasis study.

Safety Study of BMS-986165 in Healthy Subjects and to Treat Psoriasis

The purpose of this study is to establish if BMS-986165 is safe and effective at treating autoimmune diseases such as psoriasis. BMS-986165 which has shown some promise in preclinical studies for inhibiting autoimmune conditions such as psoriasis. This study will be the first time this drug is given to humans. It will be run in 5 Parts. Part A will investigate single oral doses of drug. Part B will investigate giving the drug daily for 14 days. Part C will investigate daily dos...

An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis

The purpose of this study is to investigate the experimental medication BMS-986165 compared to placebo and a currently available treatment in participants with moderate to severe plaque psoriasis.


More From BioPortfolio on "986165 diflunisal Healthy Participants"

Quick Search